ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Concomitant Azathioprine and Warfarin Warrants Significant Warfarin Dosage Increase

    L. Bowman, K. Bain, J. Hagopian, J. Iuppa, J. Shuster, T. Horwedel

    Barnes-Jewish Hospital, St. Louis, MO

    Purpose: The concomitant use of azathioprine (AZA) and warfarin (WAR) occurs commonly in solid organ transplant (SOT) recipients. Case reports in non-SOT patients have suggested…
  • 2013 American Transplant Congress

    Liver Allografts Do Not Always Protect from Kidney Allograft Rejection in Sensitized Recipients of Simultaneous Liver-Kidney Transplants

    O. Bestard, J. Cruzado, O. Taco, L. Lladó, E. Melilli, J. Fabregat, S. Gil-Vernet, A. Rafecas, J. Grinyó

    Renal Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona, Spain; Liver Transplant Unit, Bellvitge University Hospital, Barcelona, Spain; Nefrology Department, Hospital San Vicente de Paul, Bogota

    Objectives: To determine the impact of pre-existing and de novo circulating anti-HLA antibodies (DSA or not, in simultaneous liver-kidney transplants (SLKT).Methods: Thirty-nine adult recipients underwent…
  • 2013 American Transplant Congress

    Coronary Angiography in Asymptomatic Kidney Transplant Candidates?

    C. Lawrence, S. Cruickshank, A. Manoj, S. Mathavakkannan, S. Chandna, S. Fluck, K. Farrington

    Renal Unit, Lister Hospital, Stevenage, United Kingdom

    Patients with end stage renal failure are at high risk of coronary artery disease (CAD). In transplant patients death with function due to cardiovascular disease…
  • 2013 American Transplant Congress

    Early Acute Rejection (AR) Initiates Alloimmune Mechanisms Ultimately Leading to Kidney Graft Failure

    M. El Ters, M. Keddis, E. Rodrigo, A. Muriithi, M. Stegall, F. Cosio

    Nephrology,Transplant Center, Mayo Clinic, Rochester, MN; Surgery, Transplant Center, Mayo Clinic, Rochester, MN

    Introduction: AR increases risk of kidney allograft failure. The exact process by which AR leads to graft loss is yet unclear. We examined the causes…
  • 2013 American Transplant Congress

    Is Dysfunction of the HNF-1 Beta Gene Involved in the Pathogenesis of New-Onset Diabetes after Transplantation?

    G. van Boekel, M. van den Beukel, B. de Kort, C. Lamper, M. Strik, L. Hilbrands

    Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background: A dysfunction of the HNF-1beta gene can lead to renal loss of magnesium, hyperuricemia and diabetes mellitus. There is a striking similarity between this…
  • 2013 American Transplant Congress

    Reducing HIV / HCV Infection Transmission from Organ Transplantation through Nucleic Acid Testing of All Potential Deceased Donors: A Cost-Effectiveness Analysis

    J. Lai, J. Kahn, M. Tavakol, M. Peters, J. Roberts

    UCSF, San Francisco

    Background: Compared to antibody (Ab) tests, nucleic acid-amplification tests (NAT) shorten the window period during which HIV/HCV infection cannot be detected. We aimed to evaluate…
  • 2013 American Transplant Congress

    Histology One Year Post-Kidney Transplant Relates to Risk of Alloimmune-Mediated Graft Failure Long Term

    M. El Ters, L. Cornell, E. Rodrigo, M. Keddis, A. Muriithi, M. Stegall, F. Cosio

    Nephrology,Transplant Center, Mayo Clinic, Rochester, MN; Pathology, Mayo Clinic, Rochester, MN; Surgery, Transplant Center, Mayo Clinic, Rochester, MN

    Introduction. One year protocol biopsies (PBx) distinguish a large group of grafts with normal histology/mild fibrosis (GIF) and low risk of failure (LwR) from a…
  • 2013 American Transplant Congress

    Sterile Leukocyturia Predicts Interstitial Fibrosis and Tubular Atrophy in Kidney Allograft Protocol Biopsies

    S. Coelho, O. Bestard, N. Porta, E. Melilli, O. Taco, I. Rivas, J. Grinyo, J. Cruzado

    Nephrology, Hospital Fernando Fonseca, Lisbon, Portugal; Nephrology, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Biostatistics, UCICEC-CAIBER, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

    In kidney allograft protocol biopsies the presence of interstitial fibrosis and tubular atrophy (IF/TA) is associated with graft loss. In this study we sought to…
  • 2013 American Transplant Congress

    Impact of Anatomical Variations and Insufficient Liver Volume on Living Liver Donation, The

    W. Al-hamoudi, N. Allam, H. Elsiesy, A. Hashim, B. Hegab, Y. El-Sheikh, M. Al-sofayan, H. Albahili, D. Broering, M. Al sebayel, F. Abaalkhail

    King Saud University, Riyadh, Saudi Arabia; Liver Transplantatiom, King Faisal Specialist Hospital, Riyadh, Saudi Arabia

    Background and Aims: Organ shortage has been the ongoing obstacle to expand liver transplantation world-wide including Saudi Arabia. Living donor liver transplantation (LDLT) was hoped…
  • 2013 American Transplant Congress

    Project NOTIFY: A Global Database of Serious Adverse Events and Reactions in Organs, Tissues, and Cells

    M. Ison, D. Strong, D. Fehily, E. Chatzixiros, A. Costa, L. Noel

    Divisions of Infectious Diseases & Organ Transplantation, Northwestern University, Chicago; Orthopaedics and Sports Medicine, University of Washington, Seattle; National Transplant Center (CNT), Rome, Italy; Department of Essential Health Technologies, World Health Organization, Geneva, Switzerland

    Background: Serious adverse reactions and events (SAREs) are a threat to the safety and outcome of transplantation. World Health Assembly Resolution WHA 63.22 urges Member…
  • « Previous Page
  • 1
  • …
  • 1528
  • 1529
  • 1530
  • 1531
  • 1532
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences